home / stock / adma / adma articles

ADMA Articles, ADMA Biologics Inc - From 07/18/24

Stock Information
Company Name: ADMA Biologics Inc
Stock Symbol: ADMA
Market: NASDAQ
Website: admabiologics.com
Menu
ADMA ADMA Quote ADMA Short ADMA News ADMA Articles ADMA Message Board
Get ADMA Alerts

News, Short Squeeze, Breakout and More Instantly...
Leslie's Issues Preliminary Financial Results, Joins Beyond Meat, Domino's And Other Big Stocks Moving Lower In Thursday's Pre-Market Session | Benzinga

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 50 points on Thursday. Shares of Leslie’s, Inc. (NASDAQ:LE...
Is ADMA Biologics Stock Outpacing Its Medical Peers This Year? | Benzinga

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Adma Bio...

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly fina...

Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks were mostly higher, with the Dow Jones gaining over 100 points on Friday. Shares of Genpact Limited (NYSE:G) rose sharply during Friday...
ADMA Biologics Analysts Increase Their Forecasts After Upbeat Results | Benzinga

ADMA Biologics, Inc. (NASDAQ:ADMA) reported better-than-expected first-quarter financial results and issued strong revenue guidance on Thursday. AD...

ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024 | Benzinga

RAMSEY, N.J. and BOCA RATON, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) ("ADMA" or the "Company"), an end-to-end ...

Bristol-Myers Q1 Loss Narrower Than Expected, Sales Beat | Benzinga

Bristol-Myers Squibb Company (NYSE: BMY) reported an adjusted loss per share of $4.40, narrower than the Zacks Consensus Estimate of a loss of $4.5...
Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study | Benzinga

Shares of Moderna (NASDAQ: MRNA) rose 6.2% on Apr 9 after management announced encouraging data from a portion of an early-stage study on mRNA-4157...

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference | Benzinga

RAMSEY, N.J. and BOCA RATON, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) ("ADMA" or the "Company"), an end-to-en...

ADMA Biologics Announces CFO Transition | Benzinga

RAMSEY, N.J. and BOCA RATON, Fla., Feb. 28, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) ("ADMA" or the "Company"), an end-to-end...
Previous 10 Next 10